Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
29 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/29/3090267/0/en/Alzamend-Neuro-Announces-Dosing-of-First-Patient-in-its-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
19 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/19/3083965/0/en/Alzamend-Neuro-Enrolls-First-Patient-in-its-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3080073/0/en/Alzamend-Neuro-Initiates-First-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
08 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/08/3077215/0/en/Alzamend-Neuro-Announces-Reverse-Stock-Split.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076076/0/en/Alzamend-Neuro-Partners-with-QMENTA-to-Advance-AI-Powered-Imaging-for-its-Phase-II-Clinical-Trial-of-AL001-Study-to-Take-Place-at-Massachusetts-General-Hospital.html
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048659/0/en/Alzamend-Neuro-Announces-Initiation-Date-of-Phase-II-Clinical-Trial-of-AL001-for-Treatment-of-Alzheimer-s-Disease-to-take-Place-at-Massachusetts-General-Hospital.html
ABOUT THIS PAGE